Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

Image Credit: Dusan Petkovic - stock.adobe.com
Drinking Water Contaminants Linked to Higher Chronic Kidney Disease Risk

July 11th 2025

Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic kidney disease.

Medical personnel filing a syringe needle | Image Credit: MargJohnsonVA - stock.adobe.com.jpeg
SGLT2 Inhibitor Offers Kidney Protection and Reduces Heart Failure Risk After Acute Myocardial Infarction

July 10th 2025

FDA Approved. | Image Credit: Nirusmee - stock.adobe.com .jpeg
Oxylanthanum Carbonate Fails to Secure FDA Approval for Hyperphosphatemia, CKD

June 30th 2025

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com
Smartphone-Powered CKD Screening Yields 2.5-Fold Increase in Testing, Early Diagnoses

June 27th 2025

Clinical trial researchers interact with data | Image Credit: elenabsl - stock.adobe.com .jpeg
Lorundrostat Yields Promising Results for Treatment of Hypertension in Patients with CKD and Albuminuria

June 20th 2025

More News

Contributor: The Wrong Way to Design a Medicare Mandatory Demonstration
November 27th 2020

Contributor: The Wrong Way to Design a Medicare Mandatory Demonstration

Jackson Williams, JD
Jackson Williams is vice president, public policy at Dialysis Patient Citizens. Previously he worked at the Centers for Medicare and Medicaid Services (CMS); was a health services researcher in the AARP Public Policy Institute; and a lobbyist on health policy issues for 3 nonprofit associations. His more than 2 decades of experience monitoring, studying, and overseeing federal demonstration projects include time as a project officer at CMMI and serving as the consumer representative on a Medicare pilot site’s governing body.
Dr George Bakris Discusses Next Steps for Finerenone
November 27th 2020

Dr George Bakris Discusses Next Steps for Finerenone

If results from FIGARO-DKD are as positive as those of FIDELIO-DKD, the field will work aggressively to get the message out, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
Dr George Bakris Speaks About Increasing Minority Representation in CKD Trials
November 21st 2020

Dr George Bakris Speaks About Increasing Minority Representation in CKD Trials

In the FIDELIO-DKD trial researchers purposely recruited centers that had very large African American databases, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
Even in Advanced CKD, Canaglifozin Slows Rate of Kidney Decline, Study Says
November 19th 2020

Even in Advanced CKD, Canaglifozin Slows Rate of Kidney Decline, Study Says

Allison Inserro
A new analysis of CREDENCE data showed that the sodium-glucose cotransporter 2 (SGLT2) inhibitor worked in advanced disease and without causing acute kidney injury.
Dr Rajiv Agarwal on the Future of Finerenone
November 13th 2020

Dr Rajiv Agarwal on the Future of Finerenone

The FIDELIO-DKD program is perhaps just the beginning of seeing how finerenone can be used, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.
Site Logo
November 11th 2020

Primary Care Referrals to Nephrology in Patients With Advanced Kidney Disease

Ajay Dharod, MD Richa Bundy, MPH Gregory B. Russell, MS William Y. Rice III, MD Cameron E. Golightly, DO Gary E. Rosenthal, MD Barry I. Freedman, MD
Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.
kidneys
November 5th 2020

The Kidney Community Advances Innovative Solutions and Improves Patient Care—Even During a National Pandemic Crisis

Anupam Agarwal, MD, FASN John P. Butler
Authors from the American Society of Nephrology and Kidney Care Partners discuss the response of the kidney care community to the COVID-19 pandemic.
Dr Joshua Rein Discusses the Next Steps of Cannabis Treatment for Kidney Disease
October 31st 2020

Dr Joshua Rein Discusses the Next Steps of Cannabis Treatment for Kidney Disease

The federal illegality and Schedule I listing of cannabis significantly impair our ability to conduct any kind of prospective clinical research, said Joshua L Rein, DO, FASN, a nephrologist at Mt. Sinai Hospital in New York City.
Stethoscope on US flag
October 30th 2020

Research Highlights Impact of SDOH on Veterans With CKD

Gianna Melillo
A pair of abstracts presented at Kidney Week 2020 underscore the relationship between social determinants of health (SDOH) and chronic kidney disease (CKD) in military populations and the challenges of tracking these factors.
Jardiance
October 24th 2020

Empagliflozin Cuts Risk of CV, Kidney Events in Heart Failure Regardless of CKD Status

Mary Caffrey
New results from EMPEROR-Reduced presented at Kidney Week 2020.
Nkinsi
October 16th 2020

UW Medical Students Force Change to Key Kidney Measure to End Disparity

Mary Caffrey
Prompted by students, the medical school overturned a longstanding diagnostic protocol that was not well-founded in evidence.
dialysis
October 14th 2020

Dialysis Is on the Ballot Again in California

AJMC Staff
For-profit dialysis centers are spending heavily to defeat the measure.
blood pressure cuff
October 10th 2020

Surgeon General Issues Call to Action on Hypertension

Mary Caffrey
The recent focus on disparities in health care comes through in the call to action.
Dapagliflozin Gets Breakthrough Therapy Designation for CKD
October 2nd 2020

Dapagliflozin Gets Breakthrough Therapy Designation for CKD

Mary Caffrey
The FDA action follows presentation of results in August during the European Society of Cardiology 2020 Virtual Congress.
New VERTIS-CV Analysis Finds Renal Benefits for Ertugliflozin on Par With Other SGLT2s
September 29th 2020

New VERTIS-CV Analysis Finds Renal Benefits for Ertugliflozin on Par With Other SGLT2s

Mary Caffrey
A new analysis shows that ertugliflozin matched renal results seen in trials for a pair of rival sodium glucose cotransporter 2 (SGLT2) inhibitors.
ESMO
September 21st 2020

Combo for Metastatic Kidney Cancer Cuts Death Risk 40%

AJMC Staff
Nivolumab, a checkpoint inhibitor, and cabozantinib, a targeted therapy, produced dramatic results when used in combination for patients with newly diagnosed advanced kidney cancer.
kidney
September 20th 2020

Reducing Urinary Protein Improves Survival for Patients With Rare Kidney Disease

Mary Caffrey
Researchers suggest that clinical trial design could be shaped by measuring reductions in urinary protein.
HHS Secretary Alex Azar
September 18th 2020

CMS Finalizes Kidney Care Model to Promote Home Dialysis, Live Donor Transplants

Mary Caffrey
Trump administration officials said the new payment incentives represent the biggest change in kidney care in decades.
Thyroid, Kidney Cancer on Rise Among Adolescents and Young Adults
September 18th 2020

Thyroid, Kidney Cancer on Rise Among Adolescents and Young Adults

Mary Caffrey
Kidney cancer rose at least 3% a year during the years studied among adolescents and young adults, according to data from the American Cancer Society.
Oral Treatment for Renal Anemia Draws Attention From Congress
September 10th 2020

Oral Treatment for Renal Anemia Draws Attention From Congress

Mary Caffrey
Members of Congress introduce a bill to force Medicare to cover a drug they say will protect CKD patients during the COVID-19 pandemic.
cardiac rehab
September 10th 2020

For Renal Function, Cardiac Rehab Provides the Most Benefit to Those Who Most Need It

AJMC Staff
A study suggests cardiac rehabilitation offers the most benefits to patients who start out with more advanced renal disease.
Dr Milton Packer Highlights Renal Outcomes of EMPEROR Reduced
September 5th 2020

Dr Milton Packer Highlights Renal Outcomes of EMPEROR Reduced

In the past 30 years, we've never seen a heart failure drug that has had such a beneficial effect on the kidneys, said Milton Packer, MD, a distinguished scholar in cardiovascular science at Baylor University Medical Center in Dallas, and chair of the department of clinical sciences at the University of Texas Southwestern Medical School.
kidney care
September 4th 2020

From Clinical Trial to Clinical Practice: How Can DAPA-CKD Lead to Prevention in Renal Care?

Mary Caffrey
Kidney failure is one of the expensive conditions in health care, but new results from the DAPA-CKD trial could change the equation in favor of prevention.
kidney with PKD
August 27th 2020

Study on Genetic Testing for Kidney Disease in Embryos Highlights Access, Coverage Issues

Mary Caffrey
A Dutch study shows how genetic testing can help couples avoid passing devastating kidney diseases to their children, but it raises issues of disparities.
AI
August 23rd 2020

AstraZeneca, RenalytixAI Announce Collaboration in Cardiovascular, Renal, and Metabolic Disease

AJMC Staff
A proprietary algorithm can help payers identify patients at high risk of progressive chronic kidney disease.
Tobias Huber
August 19th 2020

Lancet: COVID-19 Virus Can Attack Kidneys, Speeding Death

Mary Caffrey
German researchers find viral RNA in kidneys of patients who died from COVID-19.
HHS logo
August 18th 2020

Administration Offers Progress Report on Kidney Care Initiative

Mary Caffrey
An HHS report outlines efforts to reduce kidney failure and increase options such as home-based dialysis. COVID-19 has made kidney care a higher priority.
Contributor: Does Medicare Support Coordinated Care for Those on Dialysis? Actions Speak Louder than Words
August 15th 2020

Contributor: Does Medicare Support Coordinated Care for Those on Dialysis? Actions Speak Louder than Words

LaVarne A. Burton
A new rule makes it impossible for patients with end-stage renal disease (ESRD) to take part in Medicare Advantage, leaving them out of coordinated care.
Research to Examine Renal Failure Associated With Cardiomyopathy
August 12th 2020

Research to Examine Renal Failure Associated With Cardiomyopathy

AJMC Staff
A Marshall University researcher received $444,000 from NIH to continue researching a new treatment target in chronic renal failure.
Contributor: Under New Rule, MA Plans Can Keep a Blindfold on Dialysis Facility Choice for Individuals With Kidney Failure
August 8th 2020

Contributor: Under New Rule, MA Plans Can Keep a Blindfold on Dialysis Facility Choice for Individuals With Kidney Failure

Lori Hartwell
A rule change to let those with end-stage renal disease enroll in Medicare Advantage has a twist that could stop patients from learning if their dialysis center iis in the network.
<1
...
5678910111213>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo